Frank Pallone actually said...

"I hope moving forward that both agencies will work with the committee on the discussion draft circulated today."

"It is important that, as the committee considers this issue, we have a better understanding of the strengths and limitations of both FDA and CMS's authority in this area."

"We are also very concerned about this deemed-approved approach. It essentially says if we don't make it decision in time, it is approved."

"It does not make sense to regulate tests differently based on who develops them."